Newron Pharmaceuticals S.p.A. (SWX: NWRN)
8.57
+0.08 (0.94%)
Sep 4, 2024, 4:36 PM CET
Newron Pharmaceuticals Revenue
In the year 2023, Newron Pharmaceuticals had annual revenue of 17.20M EUR, down -4.27%. Newron Pharmaceuticals had revenue of 9.42M in the half year ending December 31, 2023, with 99.17% growth.
Revenue
17.20M EUR
Revenue Growth
-4.27%
P/S Ratio
17.97
Revenue / Employee
781.77K EUR
Employees
22
Market Cap
161.81M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.20M | -768.00K | -4.27% |
Dec 31, 2022 | 17.97M | -959.00K | -5.07% |
Dec 31, 2021 | 18.93M | -2.71M | -12.52% |
Dec 31, 2020 | 21.63M | 5.64M | 35.25% |
Dec 31, 2019 | 16.00M | -32.29M | -66.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition